Клиническое наблюдение перстневидноклеточного рака желудка у ребенка. Эндоскопическая диагностика

Злокачественные новообразования (ЗНО) желудочно-кишечного тракта (ЖКТ) у детей встречаются крайне редко и составляют 1,2 % среди всех ЗНО. Согласно данным научной литературы, частота распространения рака желудка (РЖ) составляет не более чем 0,05 % среди всех случаев ЗНО ЖКТ у детей. В отечественной и зарубежной литературе описаны лишь единичные случаи РЖ у детей и подростков в возрасте от 10 до 18 лет. Клинические проявления заболевания, как и у пациентов в возрасте старше 18 лет, носят неспецифический характер – боли в эпигастрии, снижение аппетита, потеря массы тела, асцит, анемия, мелена и др. В связи с этим постановка диагноза происходит на поздних стадиях болезни и, следовательно, характеризуется неблагоприятным прогнозом. Перстневидноклеточный РЖ (ПКРЖ) является редким гистологическим подтипом аденокарциномы и встречается, как правило, у людей в возрасте от 20 до 40 лет. В данной работе представлен редкий случай развития ПКРЖ у ребенка 14 лет.

1. Brecht I.B., Graf N., Schweinitz D.V., Fruhwald M.C., Bielack S.S., Schneider D.T. Networking for children and adolescents with very rare tumors: foundation of the GROH pediatric rare tumor group. Klinische Padiatrie. 2009;221(3):181–5. doi: 10.1155/2014/527471.

2. Zhang W., Liang W.Q., Cai A.Z., Wang P.P., Xi H.Q., Liu G.X., Wei B. Clinicopathological characteristics of gastric cancer in adolescents aged 10–24 years: 17-year experience of 17 years in a single institute. Zhonghua Wei Chang Wai Ke Za Zhi. 2020;23(10):963–8. doi: 10.3760/cma.j.cn.441530-20190918-00351.

3. Al-Hussaini А., AlGhamdi S., Alsaaran R., Al-Kasim F., Habib Z., Ourfali N. Gastric adenocarcinoma presenting with gastric outlet obstruction in a child. Case Rep Gastrointest Med. 2014;2014:527471. doi: 10.1155/2014/527471.

4. Сhang V.Y., Federman N., Martinez-Agosto J., Tatishchev S.F., Nelson S.F. Whole exome sequencing of pediatric gastric adenocarcinoma reveals an atypical presentation of Li-Fraumeni syndrome. Pediatr Blood Cancer. 2013;60:570–4. doi: 10.1002/pbc.24316.

5. Lee Y.T., Ng E.K., Hung L.C., Chung S.C., Ching J.Y., Chan W.Y., Chu W.C., Sung J.J. Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients. Gut. 2005;54:1541–5. doi: 10.1136/gut.2004.055772.

6. Ассоциация онкологов России, Российское общество клинической онкологии. Клинические рекомендации «Рак желудка». M., 2020. 95 c.

7. Harting M.T., Blakely M.L., Herzog C.E., Lally K.P., Ajani J.A., Andrassy R.J. Treatment issues in pediatric gastric adenocarcinoma. J Pediatr Surg. 2004;39(8):8–10. doi: 10.1016/j.jpedsurg.2004.04.043.

8. Subbiah V., Varadhachary G., Herzog C.E., Huh W.W. Gastric adenocarcinoma in children and adolescents. Pediatr Blood Cancer. 2011;57:524–7. doi: 10.1002/pbc.23051.

9. Kato S., Kikuchi S., Nakajima S. When does gastric atrophy develop in Japanese children? Helicobacter. 2008;13:278–81. doi: 10.1111/j.1523-5378.2008.00611.x.

10. Brenner H., Arndt V., Stürmer T., Stegmaier C., Ziegler H., Dhom G. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer. 2000;88(2):274–9. doi: 10.1002/(sici)1097-0142(20000115)88:2<274::aid-cncr5>3.0.co;2-9.

11. Blaser M.J., Chyou P.H., Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res. 1995;55(3):562–5. PMID: 7834625.

12. Mauad E.C., Nogueira J.L., Souza J.M., Wohnrath D.R., Oliveira A.T., Colli G., Colli A.M. Gastric Cancer in Young Adults. Rev Bras Cancerol. 2000;46(3):299–304. doi: 10.32635/2176-9745.RBC.2000v46n3.

13. Sasaki H., Sasano H., Ohi R., Imaizumi M., Shineha R., Nakamura M., Shibuya D., Hayashi Y. Adenocarcinoma at the esophageal gastric junction arising in an 11-year-old girl. Pathol Int. 1999;49(12):1109–13. doi: 10.1046/j.1440-1827.1999.00993.x.

14. Lu J., Huang C.M., Zheng C.H., Li P., Xie J.W., Wang J.B., Lin J.X. Gastric carcinoma in a 12-year-old girl: a case report and literature review. Zhonghua Weichang Waike Zazhi. 2012;15(9):967–70. PMID: 22990936.

15. Kim D.Y., Ryu S.Y., Kim Y.J., Kim S.K. Clinicopathological characteristics of gastric carcinoma in young patients. Langenbecks Arch Sur. 2003;388(4):245–9. doi: 10.1007/s00423-003-0387-1.

16. Shin S.Y., Park H., Chae S.W., Woo H.Y. Microangiopathic hemolytic anemia as the fi rst manifestation of metastatic signet ring cell carcinoma of unknown origin: a case report and review of literature. Korean J Lab Med. 2011;31(3):157–61. doi: 10.3343/kjlm.2011.31.3.157.

17. Chu P.G., Weiss L.M. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol. 2004;121(6):884–92. doi: 10.1309/A09E-RYMF-R64N-ERDW.

18. Nagtegaal I.D., Odze R.D., Klimstra D., Paradis V., Rugge M., Schirmacher P., Washington K.M., Carneiro F., Cree I.A. The 2019 WHO classifi cation of tumours of the digestive system. Histopathology. 2020;76(2):182–8. doi: 10.1111/his.13975.

19. Pernot S., Voron T., Perkins G., Lagorce-Pages C., Berger A., Taieb J. Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge. World J Gastroenterol. 2015;21(40):11428–38. doi: 10.3748/wjg.v21.i40.11428.

20. Давыдов М.И., Тер-Ованесов М.Д., Абдихакимов А.Н. Рак желудка: предоперационное обследование и актуальные вопросы стадирования. Практическая онкология. 2003;3:9–17.

21. Curtis J.L., Burns R.C., Wang L., Mahour G.H., Ford H.R. Primary gastric tumors of infancy and childhood: 54-year experience at a single institution. J Pediatr Surg. 2008;43(8):1487–93. doi: 10.1016/j.jpedsurg.2007.11.016.

22. Tessler R.A., Dellinger M., Richards M.K., Goldin A.B., Beierle E.A., Doski J.J., Goldfarb M., Langer M., Nuchtern J.G., Raval M.V., Vasudevan S., Gow K.W. Pediatric gastric adenocarcinoma: A National Cancer Data Base review. J Pediatr Surg. 2019;54(5):1029–34. doi: 10.1016/j.jpedsurg.2019.01.048.

23. Slotta J.E., Heine S., Kauff els A., Krenn T., Grünhage F., Wagner M., Graf N., Schilling M.K., Schuld J. Gastrectomy with isoperistaltic jejunal parallel pouch in a 15-year-old adolescent boy with gastric adenocarcinoma and autosomal recessive agammaglobulinemia. J Pediatr Surg. 2011;46:e21–4. doi: 10.1016/j.jpedsurg.2011.06.005.

24. Varadhachary G., Ajani J.A. Preoperative and adjuvant therapies for upper gastrointestinal cancers. Expert Rev Anticancer Ther. 2005;5:719–25. doi: 10.1586/14737140.5.4.719.

25. Bartley A.N., Washington M.K., Colasacco C., Ventura C.B., Ismaila N., Benson A.B. 3rd, Carrato A., Gulley M.L., Jain D., Kakar S., Mackay H., Streutker C., Tang L., Troxell M., Ajani J.A. HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society of Clinical Pathology, and American Society of Clinical Oncology. J Clin Oncol. 2017;35(4):446–64. doi: 10.1200/JCO.2016.69.4836.

26. Bartley A.N., Fitzgibbons P.L., Broaddus R.R., Shi C. Template for Reporting Results of DNA Mismatch Repair Testing in Patients Being Considered for Checkpoint Inhibitor Immunotherapy. College of American Pathologists 2018;1–2.

27. Le D.T., Uram J.N., Wang H., Bartlett B.R., Kemberling H., Eyring A.D., Skora A.D., Luber B.S., Azad N.S., Laheru D., Biedrzycki B., Donehower R.C., Zaheer A., Fisher G.A., Crocenzi T.S., Lee J.J., Duff y S.M., Goldberg R.M., de la Chapelle A., Koshiji M., Bhaijee F., Huebner T., Hruban R.H., Wood L.D., Cuka N., Pardoll D.M., Papadopoulos N., Kinzler K.W., Zhou S., Cornish T.C., Taube J.M., Anders R.A., Eshleman J.R., Vogelstein B., Diaz L.A. Jr. PD-1 Blockade in Tumors with Mismatch-Repair Defi ciency. N Engl J Med. 2015;372(26):2509–20. doi: 10.1056/NEJMoa1500596.

28. Joshi S.S., Badgwell B.D. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264–79. doi: 10.3322/caac.21657.

29. Blair V.R., McLeod M., Carneiro F., Coit D.G., D’Addario J.L., van Dieren J.M., Harris K.L., Hoogerbrugge N., Oliveira C., van der Post R.S., Arnold J., Benusiglio P.R., Bisseling T.M., Boussioutas A., Cats A., Charlton A., Schreiber K.E.C., Davis J.L., Pietro M.D., Fitzgerald R.C., Ford J.M., Gamet K., Gullo I., Hardwick R.H., Huntsman D.G., Kaurah P., Kupfer S.S., Latchford A., Mansfi eld P.F., Nakajima T., Parry S., Rossaak J., Sugimura H., Svrcek M., Tischkowitz M., Ushijima T., Yamada H., Yang H.K., Claydon A., Figueiredo J., Paringatai K., Seruca R., Bougen-Zhukov N., Brew T., Busija S., Carneiro P., DeGregorio L., Fisher H., Gardner E., Godwin T.D., Holm K.N., Humar B., Lintott C.J., Monroe E.C., Muller M.D., Norero E., Nouri Y., Paredes J., Sanches J.M., Schulpen E., Ribeiro A.S., Sporle A., Whitworth J., Zhang L., Reeve A.E., Guilford P. Hereditary diff use gastric cancer: updated clinical practice guidelines. Lancet Oncol. 2020;21(8):e386–97. doi: 10.1016/S1470-2045(20)30219-9.

30. Joshi S.S., Badgwell B.D. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264–79. doi: 10.3322/caac.21657.

31. Namikawa K., Kawachi H., Tsugeno Y., Nakajima T., Fujisaki J. Detection of multiple intramucosal signet-ring cell carcinomas by white-light endoscopy and magnifying endoscopy with narrow-band imaging in a hereditary diff use gastric cancer patient with a CDH1 germline mutation. VideoGIE. 2021;13;6(4):163–6. doi: 10.1016/j.vgie.2020.11.020.

32. Fujiyoshi M.R.A., Inoue H., Fujiyoshi Y., Nishikawa Y., Toshimori A., Shimamura Y., Tanabe M., Ikeda H., Onimaru M. Endoscopic Classifi cations of Early Gastric Cancer: A Literature Review. Cancers. 2022;14(1):100. doi: 10.3390/cancers14010100.

33. Phalanusitthepha C., Grimes K.L., Ikeda H., Sato H., Sato C., Hokierti C., Inoue H. Endoscopic features of early-stage signet-ringcell carcinoma of the stomach. World J Gastrointest Endosc. 2015;7(7):741–6. doi: 10.4253/wjge.v7.i7.741.

34. Zhou H., Li M. The Value of Gastric Cancer Staging by Endoscopic Ultrasonography Features in the Diagnosis of Gastroenterology. Comput Math Methods Med. 2022;18(2022):6192190. doi: 10.1155/2022/6192190.

35. Morgant S., Artru P., Oudjit A., Lourenco N., Pasquer A., Walter T., Gornet J.M., Rouquette A., Brezault C., Coriat R. Endoscopic ultrasound efficacy in staging gastric linitisplastica lesion: a retrospective multicentric French study. Ann Transl Med. 2021;9(1):50. doi: 10.21037/atm-20-3474.